A recent piece published in the New England Journal of Medicine by MSF’s Tom Ellman, head of the Southern Africa Medical Unit (SAMU).
A life-saving drug that offers the best treatment for hepatitis C is unavailable in South Africa and carries an exorbitant price tag in wealthier nations such as the US.
A new MSF report 'The Right Shot: Bringing Down Barriers to Affordable and Adapted Vaccines’ has revealed that vaccinating the world’s poorest children today costs at least 68 times more than it did in 2001.
The Treatment Action Campaign (TAC), Doctors Without Borders (MSF) and SECTION27 applaud India’s decision to reject a patent application on sofosbuvir, an important new treatment for Hepatitis C.
New MSF report reveals countries struggle with skyrocketing vaccine prices amidst market shrouded in secrecy.
Drug-resistant tuberculosis (DR-TB) robbed 24-year-old Phumeza Tisile, a former Doctors Without Borders (MSF) patient of her hearing.
MSF calls on the EU to immediately reassess its policies on migrants and border controls following the death of 300 migrants in the Mediterranean Sea.
Doctors Without Borders (MSF) fieldworker Gail Womersley talks about her trip to the Central African Republic where she is bound to work as a clinical psychologist.
Read article below
Kathryn Stinson, an MSF South Africa field worker who recently returned from Sierra Leone writes about her experience.
MSF reaffirms its commitment to ensuring that all patients provide informed consent prior to receiving any medical treatment.